Answers are grounded in this paper and cite their sources.
Observational study highlights disease progression in sporadic Parkinson's Disease, suggesting a shift to biologically defined criteria for trials.
This study highlights the heterogeneity in the early Parkinson's Disease population defined by clinical diagnostic criteria and underscores the importance of shifting from clinical to biologically and functional impairment defined inclusion criteria for clinical trials. Biological drivers of stage heterogeneity must be further explored.
No takes yet. Share an insight, caveat, or question.
Gonzalez‐Latapi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: